Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Thymosin alpha1. SciClone Pharmaceuticals.

Billich A.

Curr Opin Investig Drugs. 2002 May;3(5):698-707. Review.

PMID:
12090542
2.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
4.

Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.

[No authors listed]

Drugs R D. 2005;6(3):178-85. Review.

PMID:
15869322
5.
6.

Cancer vaccine THERATOPE- Biomira.

Adis International Ltd.

Drugs R D. 2003;4(4):236-40.

PMID:
12848588
7.

Mismatched double-stranded RNA: polyI:polyC12U.

[No authors listed]

Drugs R D. 2004;5(5):297-304.

PMID:
15357629
8.
9.

Thymalfasin for the treatment of chronic hepatitis B.

Chien RN, Liaw YF.

Expert Rev Anti Infect Ther. 2004 Feb;2(1):9-16.

PMID:
15482167
10.

CpG 7909: PF 3512676, PF-3512676.

[No authors listed]

Drugs R D. 2006;7(5):312-6. Review.

PMID:
16922592
11.
13.
14.
17.

Melanoma Vaccine--AVAX Technologies: DNP-VACC, M-Vax.

[No authors listed]

BioDrugs. 2003;17(1):69-72.

PMID:
12534322
19.

Pegasys (Hoffmann-La Roche).

Barnard DL.

Curr Opin Investig Drugs. 2001 Nov;2(11):1530-8. Review.

PMID:
11763153
20.

Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study.

Mutchnick MG, Lindsay KL, Schiff ER, Cummings GD, Appelman HD, Peleman RR, Silva M, Roach KC, Simmons F, Milstein S, Gordon SC, Ehrinpreis MN.

J Viral Hepat. 1999 Sep;6(5):397-403.

Supplemental Content

Support Center